Outpatient antibiotherapy in children with neutropenia and fever: A review of the literature;Antibiothérapie ambulatoire chez les enfants neutropéniques fébriles: Analyse de la littérature

Presse Medicale

Volumn 33, Issue 5, 2004, Pages 330-337

  Leverger, Guy ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN; TEICOPLANIN;

ANTIBIOTIC THERAPY; APLASIA; CHILD; COST OF ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFECTION; OUTPATIENT CARE; RELAPSE; REMISSION; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 1542615331     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98579-x     Document Type: Review

References (39)

1. Cordonnier C, Leverger G, Schlemmer B et al. Stratégie antibiotique dans les épisodes fébriles au cours des neutropénies profondes (inférieures à 500 PNN) et prolongées (supérieures ou égales à 7 jours). Nouv Rev Fr Hematol 1994; 36: 289-91.
2. Pizzo PA, Robichaud KJ, Gill FA et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979; 67: 194-200.
3. Hann I, Viscoli C, Paesmans M et al. A comparison o outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. Br J Haematol 1997; 99: 580-8.
4. Hugues WT, Armstrong D, Bodey GP et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551-73.
5. Mullen CA. Which children with fever and neutropenia can be safely treated as outpatients? Br J Haematol 2001; 112: 832-7.
6. Mullen CA, Buchanan GR. Early hospital discharge o children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. J Clin Oncol 1990; 8: 1998-2004.
7. Griffin TC, Buchanan GR. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital. J Pediatr 1992; 121: 28-33.
8. Katz JA, Mustafa MM. Management of fever in granulocytopenic children with cancer. Pediatr Infect Dis J 1993; 12: 330-9.
9. Bash RO, Katz JA, Cash J, Buchanan GR. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 1994; 74: 189-96.
10. Aquino VM, Buchanan GR, Tkaczewski I, Mustapha MM. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol 1997; 28: 191-5.
11. Jones GR, Konsler GK, Dunaway RP et al. Risk factor for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition. J Pediatr 1994; 124: 703-8.
12. Cohen KJ, Leamer K, Odom L et al. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. J Pediatr Hematol Oncol 1995; 17: 325-30.
13. Wacker P, Halperin DS, Wyss M et al. Early hospital discharge of children with fever and neutropenia: a prospective study. J Pediatr Hematol Oncol 1997; 19: 208-211.
14. Santolaya ME, Villarroel M, Avendano LF et al. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study. Clin Infect Dis 1997; 25: 92-7.
15. Malik IA, Abbas Z, Karim M. Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 1992; 339: 1092-6.
16. Freifeld A, Marchigiani D, Walsh T et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305-11.
17. Kern WV, Cometta A, de Bock R et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312-18.
18. Shenep JL, Flynn PM, Baker DK et al. Oral Cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis 2001; 32: 36-43.
19. Rubenstein EB, Rolston K, Berjamin RS et al. Outpatient treatment of febrile episodes in low risk neutropenic patients with cancer. Cancer 1993; 71: 3640-6.
20. Malik IA, Khan WA, Karim M et al. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995; 98: 224.
21. Talcott JA, Finberg R, Mayer RJ et al. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Int Med 1988; 148: 2561-8.
22. Talcott JA, Whalen A, Clark J et al. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994; 12: 107-14.
23. Klastersky J, Paesmans M, Rubenstein EB et al. The multinational association for supportive cafe in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18: 3038-51.
24. Mullen CA, Petropoulos D, Roberts WM et al. Outpatient treatment of fever and neutropenia for low-risk pediatric cancer patients. Cancer 1999; 86: 126-34.
25. Petrilli AS, Dantas LS, Campos MC et al. Oral Ciprofloxacin vs intravenous Ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol 2000; 34: 87-91.
26. Freifeld A, Pizzo P. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients. Pediatr Infect Dis J, 1997; 16: 140-6.
27. Wiernikowski JT, Rothney M, Dawon S et al. Evaluation of a home intravenous antibiotic program in pediatric oncology. Am J Pediatr Hematol Oncol, 1991; 13: 144-7.
28. Lau RC, Doyle JJ, Freedman MH et al. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol 1994; 11: 417-21.
29. Paganini HR, Sarkis CM, de Martino MG et al. Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer 2000; 88: 2848-52.
30. Klaassen RJ, Allen U, Doyle JJ. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia. J Pediatr Hematol Oncol 2000; 22: 405-11.
31. Mustafa MM, Aquino VM, Pappo A et al. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr 1996; 128: 847-9.
32. Sahu S, Bapna A, Pai SK et al. Outpatient antimicrobial protocol for febrile neutropenia; a non randomized prospective trial using ceftriaxone, amikacin, and oral adjuvants agents. Pediatr Hematol Oncol 1997; 14: 205-11.
33. Preis S, Jurgens H, Friedland C et al. Ceftriaxone alone or in combination with teicoplanin in the management of febrile episodes in neutropenic children and adolescents with cancer on an outpatient base. Klin Pediatr 1993; 205: 295-9.
34. Preis S, Gobel U, Jurgens H. Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer. J Pediatr 1997; 130: 500-1.
35. Kaplinski C, Drucker M, Goshen J et al. Ambulatory treatment with ceftriaxone in febrile neutropenic children. Isr J Med Sci 1994; 30: 649-51.
36. Aquino VM, Herrera L, Sandler ES, Buchanan GR. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000; 88: 1710-4.
37. Malik IA. Out-patient management of febrile neutropenia in indigent paediatric patients. Ann Acad Med Singapore 1997; 26: 742-6.
38. Shemesh E, Yaniv I, Drucker M et al. Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Med Pediatr Oncol, 1998; 30: 95-100.
39. Mullen CA, Petropoulos D, Roberts WM et al. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. J Pediatr Hematol Oncol 1999; 21: 212-18.